CN104853748A - 分层的双氢氧化物 - Google Patents

分层的双氢氧化物 Download PDF

Info

Publication number
CN104853748A
CN104853748A CN201380063531.9A CN201380063531A CN104853748A CN 104853748 A CN104853748 A CN 104853748A CN 201380063531 A CN201380063531 A CN 201380063531A CN 104853748 A CN104853748 A CN 104853748A
Authority
CN
China
Prior art keywords
ldh
materials
ldh activity
anionic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380063531.9A
Other languages
English (en)
Chinese (zh)
Inventor
C·汤普森
M·L·布拉沃科尔代罗
D·M·欧海尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Pharmascience Ltd
Original Assignee
Oxford Pharmascience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Pharmascience Ltd filed Critical Oxford Pharmascience Ltd
Publication of CN104853748A publication Critical patent/CN104853748A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
CN201380063531.9A 2012-10-05 2013-10-01 分层的双氢氧化物 Pending CN104853748A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1217911.5 2012-10-05
GBGB1217911.5A GB201217911D0 (en) 2012-10-05 2012-10-05 Layered double hydroxides
PCT/GB2013/052554 WO2014053822A1 (en) 2012-10-05 2013-10-01 Layered double hydroxides

Publications (1)

Publication Number Publication Date
CN104853748A true CN104853748A (zh) 2015-08-19

Family

ID=47294361

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380063531.9A Pending CN104853748A (zh) 2012-10-05 2013-10-01 分层的双氢氧化物

Country Status (16)

Country Link
US (1) US9642919B2 (cg-RX-API-DMAC7.html)
EP (2) EP2929876B1 (cg-RX-API-DMAC7.html)
JP (1) JP6363082B2 (cg-RX-API-DMAC7.html)
KR (1) KR20150063559A (cg-RX-API-DMAC7.html)
CN (1) CN104853748A (cg-RX-API-DMAC7.html)
AU (2) AU2013326298B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015007529A2 (cg-RX-API-DMAC7.html)
CA (1) CA2887059A1 (cg-RX-API-DMAC7.html)
EA (1) EA034124B1 (cg-RX-API-DMAC7.html)
GB (1) GB201217911D0 (cg-RX-API-DMAC7.html)
IL (1) IL237947B (cg-RX-API-DMAC7.html)
IN (1) IN2015DN02576A (cg-RX-API-DMAC7.html)
MX (1) MX2015004188A (cg-RX-API-DMAC7.html)
PH (1) PH12015500744B1 (cg-RX-API-DMAC7.html)
WO (1) WO2014053822A1 (cg-RX-API-DMAC7.html)
ZA (2) ZA201502510B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109432450A (zh) * 2018-11-23 2019-03-08 北京化工大学 一种超分子纳米化学动力药物及其在肿瘤治疗方面的应用

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201520762D0 (en) * 2015-11-24 2016-01-06 Isis Innovation Novel pharmaceutical compositions
JP6557597B2 (ja) * 2015-12-25 2019-08-07 共栄社化学株式会社 層状複水酸化物
US10882753B2 (en) 2016-09-15 2021-01-05 Paris Sciences Et Lettres—Quartier Latin Method for exchanging interlayer anions of a layered double hydroxide
EP3957604B1 (en) * 2019-04-19 2025-07-09 National Institute for Materials Science Nitrogen-based gas sustained release agent, nitrogen-based gas sustained release body comprising same, nitrogen-based gas sustained release method using sustained release body, breathing instrument, wrapping body, and sustained release device
CA3194835A1 (en) 2020-10-17 2022-04-21 David Anderson Formulation and noncovalent stabilization of olivetolic acid derivatives
WO2025192959A1 (ko) * 2024-03-13 2025-09-18 연세대학교 산학협력단 층상형 금속 인화물 혼성체 촉매, 이의 제조방법 및 이를 구비하는 수전해 장치

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1947700A (zh) * 2006-09-22 2007-04-18 北京化工大学 一种磁性超分子插层结构缓释型布洛芬及其制备方法
EP1341556B1 (en) * 2000-12-14 2008-10-15 Isis Innovation Limited Drug delivery system

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS606619A (ja) 1983-06-27 1985-01-14 Kyowa Chem Ind Co Ltd 鉄分欠乏症処置剤及びその製法
US5079203A (en) 1990-05-25 1992-01-07 Board Of Trustees Operating Michigan State University Polyoxometalate intercalated layered double hydroxides
JP3681480B2 (ja) * 1996-09-27 2005-08-10 エーザイ株式会社 薬物の不快な味を隠蔽する組成物
US6924409B2 (en) 2000-12-19 2005-08-02 Babcock & Wilcox Volund Aps Method for reducing the leaching of oxyanion forming elements, in particular chromium, from hazardous waste
JP2004091421A (ja) * 2002-09-03 2004-03-25 Tayca Corp アスコルビン酸を取り込んだ層状複水酸化物およびそれを含む化粧料組成物
US20040138511A1 (en) 2003-01-10 2004-07-15 James Butler Aromatic alkylation process with direct recycle
AU2003902178A0 (en) 2003-05-07 2003-05-22 Commonwealth Scientific And Industrial Research Organisation Stabilization of waste material
CN1297276C (zh) 2004-06-14 2007-01-31 北京化工大学 5-氨基水杨酸插层药物缓释剂及其制备方法
US20090108233A1 (en) * 2004-12-24 2009-04-30 The Univeristy Of Queensland Preparation of suspensions
US20060140994A1 (en) 2004-12-27 2006-06-29 Bagwell Alison S Application of an antimicrobial agent on an elastomeric article
MY157620A (en) * 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
CN101493404B (zh) 2008-01-21 2011-08-10 安徽帝元生物科技有限公司 一种化肥养分控失剂控失率的检测方法
CN101440281B (zh) * 2008-11-25 2011-11-23 北京化工大学 苯并咔唑插层水滑石复合发光材料及其制备方法
ZA201000350B (en) 2009-02-05 2010-12-29 Univ Pretoria A degradable polymeric material
CN101507819B (zh) * 2009-03-27 2011-01-05 北京化工大学 一种大粒径药物插层水滑石及其制备方法
CN101597474B (zh) 2009-07-03 2012-10-17 北京化工大学 增甘磷插层结构选择性红外吸收材料及其制备方法与应用
US20110040006A1 (en) 2009-08-17 2011-02-17 Basf Se Compositions with Improved Dirt Pickup Resistance Comprising Layered Double Hydroxide Particles
CN102218043B (zh) 2011-06-14 2013-03-27 宁夏医科大学 Ldh超分子组装型阿司匹林缓释片及其制备方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1341556B1 (en) * 2000-12-14 2008-10-15 Isis Innovation Limited Drug delivery system
CN1947700A (zh) * 2006-09-22 2007-04-18 北京化工大学 一种磁性超分子插层结构缓释型布洛芬及其制备方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109432450A (zh) * 2018-11-23 2019-03-08 北京化工大学 一种超分子纳米化学动力药物及其在肿瘤治疗方面的应用

Also Published As

Publication number Publication date
ZA201702869B (en) 2018-08-29
AU2013326298A1 (en) 2015-04-23
WO2014053822A1 (en) 2014-04-10
US9642919B2 (en) 2017-05-09
IL237947B (en) 2018-04-30
AU2017219016B2 (en) 2018-07-26
EP2903598A1 (en) 2015-08-12
PH12015500744A1 (en) 2015-05-25
EA034124B1 (ru) 2019-12-30
CA2887059A1 (en) 2014-04-10
EP2929876B1 (en) 2019-12-25
ZA201502510B (en) 2017-09-27
BR112015007529A2 (pt) 2017-07-04
EA201590673A1 (ru) 2015-08-31
AU2013326298B2 (en) 2017-10-05
JP6363082B2 (ja) 2018-07-25
JP2016500667A (ja) 2016-01-14
GB201217911D0 (en) 2012-11-21
IN2015DN02576A (cg-RX-API-DMAC7.html) 2015-09-11
MX2015004188A (es) 2015-07-17
PH12015500744B1 (en) 2015-05-25
KR20150063559A (ko) 2015-06-09
US20150258212A1 (en) 2015-09-17
AU2017219016A1 (en) 2017-09-07
EP2903598B1 (en) 2019-05-01
EP2929876A1 (en) 2015-10-14
WO2014053822A4 (en) 2014-05-30

Similar Documents

Publication Publication Date Title
AU2017219016B2 (en) Layered double hydroxides
EP1993514B1 (en) Granular material comprising water-insoluble inorganic phosphate binders
JP6333926B2 (ja) 混合金属化合物
EP2194972B1 (en) Mixed metal compounds used as antacids
US10272057B2 (en) Layered double hydroxides
JP2016500667A5 (cg-RX-API-DMAC7.html)
JP5394921B2 (ja) 酸化ストレスによる疾病の予防及び治療のための抗酸化剤
Shahabadi et al. Biological application of Layered double hydroxides in drug delivery systems
Chakraborty et al. Layered double hydroxides based ceramic nanocapsules as reservoir and carrier of functional anions
Fisher Pharmaceutical applications of layered double hydroxides
HK1121065B (en) Granular material comprising water-insoluble inorganic phosphate binders
AU2013263790A1 (en) Granular Material Comprising Water-Insoluble Inorganic Phosphate Binders
AU2016213745A1 (en) Granular Material Comprising Water-Insoluble Inorganic Phosphate Binders

Legal Events

Date Code Title Description
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned
AD01 Patent right deemed abandoned

Effective date of abandoning: 20210903